Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
THNR ETF · Amplify Weight Loss Drug & Treatment ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +4.17%  | -8.21%  | +17.88% | N/A | N/A | +0.09% | +0.09% | -2.95% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs in your region
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -8.21% | +17.88% | N/A | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about THNR ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
THNR’s has a Final Sustainability Grade of either A+, A, or A-.
Replication
Issuer
| AuM | ||
|---|---|---|
DIVO | Amplify CWP Enhanced Dividend Income ETF | €5.89B |
SILJ | Amplify Junior Silver Miners ETF | €3.51B |
HACK | Amplify Cybersecurity ETF | €1.67B |
BLOK | Amplify Transformational Data Sharing ETF | €1.01B |
IDVO | Amplify International Enhanced Dividend Income ETF | €976M |
Frequently asked questions about THNR
What does Amplify Weight Loss Drug & Treatment ETF, THNR, invest in?
THNR is a Passive ETF. This ETF provides exposure to Equities.
Which benchmark or index does THNR replicate?
THNR tracks the VettaFi Weight Loss Drug & Treatment Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of THNR?
THNR carries a total expense ratio (TER) of 0.59%, indicating the annual cost for holding the fund.
When was THNR launched?
THNR was introduced to the market on May 21, 2024. It trades on United States
Who is the ETF issuer of THNR?
Amplify Weight Loss Drug & Treatment ETF, THNR, is provided by Amplify ETFs. Learn more about Amplify ETFs here.
What is the current assets under management (AUM) of THNR?
THNR oversees €3.6M in assets as of April 24, 2026.
How has THNR performed lately?
Based on data from April 24, 2026, THNR returned 4.17% over the past month, -8.21% over the last three months and -2.95% year-to-date.
What are the latest inflows or outflows for THNR?
As of April 24, 2026, THNR recorded net flows of +€1.3M year-to-date.
Does THNR distribute dividends?
THNR follows a distributing dividend policy, meaning it pays out income to investors. As of April 24, 2026, its 12-month trailing yield was 1.69%.
What are the main country or region exposures of THNR?
As of March 31, 2026, THNR has significant geographic allocations in USA, Japan and Hong Kong.
In which sector or theme does THNR invest in?
As of March 31, 2026, THNR focuses largely on Health Care.
How many securities does THNR hold and how diversified is it?
As of March 31, 2026, THNR holds 19 positions in its portfolio, with 84.23% of assets concentrated in its top 15 holdings.
What are the main positions in THNR?
As of March 31, 2026, THNR top three holdings include US6701002056, LILLY and REGENERON PHARMACEUTICALS.
What is the base currency of THNR?
The base currency of THNR is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
